We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · March 05, 2015

Long-Term Androgen Deprivation Therapy Is Beneficial for Localized Prostate Cancer

The Lancet Oncology


Additional Info

The Lancet Oncology
High-Dose Radiotherapy With Short-Term or Long-Term Androgen Deprivation in Localised Prostate Cancer (DART01/05 GICOR): A Randomised, Controlled, Phase 3 Trial
Lancet Oncol 2015 Mar 01;16(3)320-327, A Zapatero, A Guerrero, X Maldonado, A Alvarez, CG Segundo, MA Rodríguez, V Macias, AP Olive, F Casas, A Boladeras, CM de Vidales, ML de la Torre, S Villà, AP de la Haza, FA Calvo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.

Further Reading